Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 13/20 | 0.40 |
| ▸ | ARG1 | P05089 | 3/20 | 0.32 |
| ▸ | ARG2 | P78540 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6060651 | 0.83 | AKT1 (0.37) | — | |
| SCHEMBL1044578 | 0.83 | — | — | |
| SCHEMBL6060680 | 0.82 | AKT1 (0.38) | — | |
| SCHEMBL1043822 | 0.81 | — | — | |
| SCHEMBL6059855 | 0.81 | AKT1 (0.33) | — | |
| SCHEMBL6060418 | 0.77 | CYP1A2 (0.33) | — | |
| SCHEMBL3783443 | 0.77 | CPB2 (0.34) | CPB2ARG1ARG2 | |
| Hydrochloric Acid SCHEMBL3773547 | 0.75 | CPB2 (0.33) | CPB2ARG1ARG2 | |
| SCHEMBL3776673 | 0.75 | CPB2 (0.40) | CPB2 | |
| Trifluoroacetic Acid SCHEMBL3780429 | 0.75 | CPB2 (0.46) | CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2272826-A1 | 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them | Les Laboratoires Servier (FR) | 2011-01-12 | — | — | EP | disclosed |
| WO-2010149888-A1 | DERIVATIVES OF 2-MERCAPTOCYCLOPENTANE CARBOXYLIC ACID, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | LES LABORATOIRES SERVIER (FR) | 2010-12-29 | — | — | WO | disclosed |